These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24175212)

  • 21. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.
    Freitas N; Cunha C; Menne S; Gudima SO
    J Virol; 2014 May; 88(10):5742-54. PubMed ID: 24623409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
    Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
    J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.
    Goyal A; Romero-Severson EO
    PLoS One; 2018; 13(9):e0203831. PubMed ID: 30192887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.
    Giersch K; Perez-Gonzalez P; Hendricks L; Goldmann N; Kolbe J; Hermanussen L; Bockmann JH; Volz T; Volmari A; Allweiss L; Petersen J; Glebe D; Lütgehetmann M; Dandri M
    JHEP Rep; 2023 Apr; 5(4):100673. PubMed ID: 36908749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional and clinical significance of hepatitis D virus genotype II infection.
    Wu JC
    Curr Top Microbiol Immunol; 2006; 307():173-86. PubMed ID: 16903226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.
    Pollicino T; Raffa G; Santantonio T; Gaeta GB; Iannello G; Alibrandi A; Squadrito G; Cacciola I; Calvi C; Colucci G; Levrero M; Raimondo G
    J Virol; 2011 Jan; 85(1):432-9. PubMed ID: 20962099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for hepatitis delta virus infection.
    Heidrich B; Manns MP; Wedemeyer H
    Curr Infect Dis Rep; 2013 Feb; 15(1):31-8. PubMed ID: 23242761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.
    Schaper M; Rodriguez-Frias F; Jardi R; Tabernero D; Homs M; Ruiz G; Quer J; Esteban R; Buti M
    J Hepatol; 2010 May; 52(5):658-64. PubMed ID: 20346531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S; Altstetter SM; Protzer U
    World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis delta virus.
    Hughes SA; Wedemeyer H; Harrison PM
    Lancet; 2011 Jul; 378(9785):73-85. PubMed ID: 21511329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assembly of hepatitis delta virus particles: package of multimeric hepatitis delta virus genomic RNA and role of phosphorylation.
    Yeh TS; Lee YH
    Virology; 1998 Sep; 249(1):12-20. PubMed ID: 9740772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and Future Management of Chronic Hepatitis D.
    Farci P; Anna Niro G
    Gastroenterol Hepatol (N Y); 2018 Jun; 14(6):342-351. PubMed ID: 30166948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
    Bogomolov P; Alexandrov A; Voronkova N; Macievich M; Kokina K; Petrachenkova M; Lehr T; Lempp FA; Wedemeyer H; Haag M; Schwab M; Haefeli WE; Blank A; Urban S
    J Hepatol; 2016 Sep; 65(3):490-8. PubMed ID: 27132170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.